Literature DB >> 11036010

Genetic analysis of azole resistance in the Darlington strain of Candida albicans.

H Kakeya1, Y Miyazaki, H Miyazaki, K Nyswaner, B Grimberg, J E Bennett.   

Abstract

High-level azole resistance in the Darlington strain of Candida albicans was investigated by gene replacement in C. albicans and expression in Saccharomyces cerevisiae. We sequenced the ERG11 gene, which encodes the sterol C(14)alpha-demethylase, from our copy of the Darlington strain. Both alleles contained the histidine for tyrosine substitution at position 132 (Y132H) reported in Darlington by others, but we also found a threonine-for-isoleucine substitution (I471T) not previously reported in the C. albicans ERG11. The encoded I471T change in amino acids conferred azole resistance when overexpressed alone and increased azole resistance when added to the Y132H amino acid sequence in an S. cerevisiae expression system. Replacement of one copy of ERG11 in an azole-susceptible strain of C. albicans with a single copy of the Darlington ERG11 resulted in expression of the integrated copy and a modest increase in azole resistance. The profound azole resistance of the Darlington strain is the result of multiple mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036010      PMCID: PMC101590          DOI: 10.1128/AAC.44.11.2985-2990.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains.

Authors:  S A Howell; A I Mallet; W C Noble
Journal:  J Appl Bacteriol       Date:  1990-11

2.  Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.

Authors:  M H Lai; D R Kirsch
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

3.  Improved method for high efficiency transformation of intact yeast cells.

Authors:  D Gietz; A St Jean; R A Woods; R H Schiestl
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

4.  Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.

Authors:  M A Pearce; S A Howell
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 5.  Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals.

Authors:  H Vanden Bossche; P Marichal; J Gorrens; D Bellens; H Moereels; P A Janssen
Journal:  Biochem Soc Trans       Date:  1990-02       Impact factor: 5.407

6.  Modified response to ketoconazole of Candida albicans from a treatment failure.

Authors:  D W Warnock; E M Johnson; M D Richardson; C F Vickers
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

7.  Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Authors:  Patrick Marichal; Luc Koymans; Staf Willemsens; Danny Bellens; Peter Verhasselt; Walter Luyten; Marcel Borgers; Frans C S Ramaekers; Frank C Odds; Hugo Vanden Bossche
Journal:  Microbiology       Date:  1999-10       Impact factor: 2.777

8.  Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans.

Authors:  Y Miyazaki; A Geber; H Miyazaki; D Falconer; T Parkinson; C Hitchcock; B Grimberg; K Nyswaner; J E Bennett
Journal:  Gene       Date:  1999-08-05       Impact factor: 3.688

9.  Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Med Vet Mycol       Date:  1987-10

10.  Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans.

Authors:  A Varma; J C Edman; K J Kwon-Chung
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more
  23 in total

1.  S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole.

Authors:  Andrew G S Warrilow; Jonathan G L Mullins; Claire M Hull; Josie E Parker; David C Lamb; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

2.  Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.

Authors:  Taiga Miyazaki; Yoshitsugu Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Shunichi Miyakoshi; John E Bennett; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents.

Authors:  Sanjib K Shrestha; Marina Y Fosso; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).

Authors:  Andrew G S Warrilow; Claire M Martel; Josie E Parker; Nadja Melo; David C Lamb; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

Review 5.  The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.

Authors:  Joachim Morschhäuser
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

6.  Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing.

Authors:  T-H Kim; M-K Lee
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

7.  Prion-forming ability of Ure2 of yeasts is not evolutionarily conserved.

Authors:  Herman K Edskes; Abbi Engel; Lindsay M McCann; Andreas Brachmann; Huei-Fung Tsai; Reed B Wickner
Journal:  Genetics       Date:  2011-03-02       Impact factor: 4.562

8.  Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.

Authors:  Stephanie A Flowers; Brendan Colón; Sarah G Whaley; Mary A Schuler; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

9.  Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.

Authors:  Herman K Edskes; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.

Authors:  Nico Dunkel; Teresa T Liu; Katherine S Barker; Ramin Homayouni; Joachim Morschhäuser; P David Rogers
Journal:  Eukaryot Cell       Date:  2008-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.